SELLAS Life Sciences (SLS) FCF Payout Ratio (2018)
SELLAS Life Sciences (SLS) reported FCF Payout Ratio of 0.03 for Q3 2018.
SELLAS Life Sciences (SLS) FCF Payout Ratio (2018) Analysis & Trends
SELLAS Life Sciences (SLS) has 1 years of FCF Payout Ratio data on file, last reported at 0.03 in Q3 2018.
- FCF Payout Ratio for Q3 2018 came in at 0.03, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was 0.02 (down 72.43% YoY), and the FY2018 annual result was 0.02, changed N/A from the prior year.
- FCF Payout Ratio held at 0.03 in Q3 2018 per SLS's latest filing.
- Over five years, FCF Payout Ratio peaked at 0.03 in Q3 2018 and troughed at 0.03 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -0.03 |